More Comparative Studies Needed to Guide Physicians
Comparative effectiveness studies currently are underutilized and should be increased to better guide
physicians in the effective everyday use of current therapies, according to a review in the March 10 issue of the
Journal of the American Medical Association.
Rosuvastatin Protects Against Reperfusion-Related Damage
Rosuvastatin protects against injury from ischemia and reperfusion through a
cyclooxygenase-2-dependent mechanism, which may explain why cyclooxygenase-2 inhibitors have negative
cardiovascular side-effects, according to a study in the March 9 issue of the Journal of the American College of
Cardiology.
Oral Drug for Post-Knee Surgery Thromboprophylaxis Assessed
Patients who undergo knee replacement surgery can be given the oral medication apixaban for
thromboprophylaxis instead of enoxaparin, and it is effective and confers no additional risk of bleeding, according
to a study in the March 6 issue of The Lancet.
Olmesartan Slows Sclerosis Progression in Angina Patients
Olmesartan, an angiotensin-II receptor blocker, slows the rate of coronary atheroma progression in
patients with stable angina pectoris, according to a study in the March 9 issue of the Journal of the American
College of Cardiology.
Statin Reduces Cardiovascular Events, Mortality in CKD
Rosuvastatin (Crestor) reduces all-cause mortality and the incidence of first cardiovascular events
among subjects with moderate chronic kidney disease, low-density lipoprotein cholesterol of less than 130 mg/dL,
and elevated high-sensitivity C-reactive protein, according to research published online March 3 in the Journal of
the American College of Cardiology.
Study Compares Drugs for Absence Epilepsy in Children
Ethosuximide and valproic acid are more effective for treating childhood absence epilepsy than
lamotrigine, and ethosuximide treatment results in fewer adverse attentional effects, according to research
published in the March 4 issue of the New England Journal of Medicine.
Norepinephrine and Dopamine Treatment for Shock Compared
in patients with shock, treatment with dopamine and norepinephrine results in similar overall death
rates, but dopamine causes more adverse events and may pose a safety risk for patients in cardiogenic shock,
according to a study in the March 4 issue of the New England Journal of Medicine.
Study Assesses Costs Related to Poor Discectomy Outcomes
The costs related to poor outcomes following discectomy may be underappreciated, and technologies to
improve outcomes could be cost-neutral even at a considerable price, according to research published in the
February issue of The Spine Journal.
AUA records victories in the Senate as 21.2% cut looms
As this issue of Urology Times went to press, passage of major health care reform
legislation—on which AUA and other health care groups had devoted considerable time, energy, and
resources—was in jeopardy.
MGMA: Practices unhappy with PQRI
Medical practice leaders continue to experience administrative challenges reporting data for
Medicare?s Physician Quality Reporting Initiative, according to results of a survey recently released by the
Medical Group Management Association. Specifically, respondents reported difficulty accessing the feedback reports
and said that the presentation of information in the reports was not satisfactory.
One-Third of 20-Somethings in U.S. Lack Health Insurance
A large proportion of young adults in the United States are without health insurance, and men in this
age group are more likely to be uninsured than women, according to a new report issued Feb. 24 by the National
Center for Health Statistics.
Physicians Working Fewer Hours for Lower Fees
Physicians in the United States have been working fewer hours for lower fees in the past decade,
according to research published in the Feb. 24 issue of the Journal of the American Medical
Association.
Novartis Updates Exjade Prescribing Information
Novartis Oncology has alerted health care professionals about changes in the prescribing information
for deferasirox (Exjade), a treatment for chronic iron overload due to blood transfusions in patients 2 years of
age and older, according to a Feb. 18 safety alert issued by the U.S. Food and Drug Administration.
FDA Reviewing Safety of HIV Antiretroviral Combination
The U.S. Food and Drug Administration has alerted health care professionals and consumers that the HIV
drug combination of saquinavir (Invirase) and ritonavir (Norvir) may increase the risk of potentially serious
cardiac arrhythmias in a dose-dependent manner.This is an early communication from the FDA with ongoing review of
the data.
Strategies Assist Doctors in Saying 'No' to Patients
When primary care physicians need to deny patient requests for tests and treatments, strategies that
incorporate the patient perspective may be most effective, according to a study in the Feb. 22 issue of the
Archives of Internal Medicine.
Hospital-Acquired Infections Impose Heavy Burden
Hospital-acquired sepsis and pneumonia impose a significant financial and clinical burden, according
to a study published in the Feb. 22 issue of the Archives of Internal Medicine, while another study found that
hospitals that keep costs down do not necessarily have poorer quality of care or higher readmission
rates.
Medical Checklists Needed to Improve Care and Outcomes
The checklists so common in aviation and many professions are underused in medicine and, if more
widely adopted, would provide powerful tools to standardize care and improve patient outcomes, according to an
article published Dec. 31 in Critical Care.
Bevacizumab Reduces Nose Bleeds in Inherited Condition
The vascular endothelial growth factor inhibitor bevacizumab administered by intranasal injection, or
even by topical nasal spray, can effectively treat epistaxis from hereditary hemorrhagic telangiectasia, according
to reports published in The Laryngoscope.
California limits appointment wait times
Ten business days is the most time California private health plan members will have to wait for a
non-urgent appointment with a primary care physician.
Halting Anticoagulants Lowers Post-Ablation Stroke Risk
Patients who undergo atrial fibrillation ablation are less likely to have a stroke if they stop taking
oral anticoagulants after a few months, according to a study in the Feb. 23 issue of the Journal of the American
College of Cardiology.
Many Adults in Utah Report Using Opioids Incorrectly
In 2008, one-fifth of adults in Utah had been prescribed an opioid pain medication in the past year,
with some respondents reporting use of these medications despite no prescription for them, according to an article
in the Feb. 19 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly
Report.
LABAs Can Harm Asthma Patients When Used Alone
The U.S. Food and Drug Administration has announced that long-acting beta agonists should never be
used alone to treat asthma in children or adults.
Initial Clopidogrel Response May Predict Final Response
In patients with acute coronary syndrome, a slow clopidogrel response within the first hour after
loading may identify those with a low response after 24 hours and high post-treatment platelet reactivity,
according to a study in the Feb. 23 issue of the Journal of the American College of Cardiology.
Drug Addition Found to Reduce Multiple Sclerosis Activity
The addition of daclizumab to interferon beta treatment reduces brain lesion formation in patients
with relapsing multiple sclerosis, possibly by increasing the number of a subset of natural killer cells, according
to a study published online Feb. 16 in The Lancet Neurology.
Drug Combo Shows Benefits in Chronic Kidney Disease
In hypertensive patients with high cardiovascular risk, benazepril and amlodipine are better at
reducing progression of chronic kidney disease than benazepril with hydrochlorothiazide, according to research
published online Feb. 18 in The Lancet.
Cardiac Effects of Hormone Replacement Therapy Studied
Hormone replacement therapy that includes estrogen plus progestin may not reduce the risk for coronary
heart disease during the first several years of treatment in women who started hormone therapy near menopause,
according to research published in the Feb. 16 issue of the Annals of Internal Medicine.
Outcomes Found to Be Poor in South Carolina Stroke Patients
In South Carolina, patients hospitalized for an initial stroke have an elevated short- and long-term
risk of recurrent stroke, heart attack, vascular death, and all-cause death, according to a study in the Feb. 16
issue of Neurology.
Treating Herpes May Slow HIV in Co-Infected Patients
In patients co-infected with HIV-1 and herpes simplex virus type 2, treating the herpes infection with
acyclovir likely delays the progression of HIV, according to a study published online Feb. 15 in The
Lancet.
Supplement Shown to Be Helpful in Metformin Patients
In patients with polycystic ovarian syndrome taking metformin, folic acid supplementation may help
enhance metformin's benefits on the vascular endothelium, and maintain homocysteine levels, according to research
published in the February issue of Diabetes Care.
Mnemonic Device for Patient Decision-Making Assessed
Clinicians who must quickly assess a patient's capacity to make an emergency treatment decision can
now fall back on a new mnemonic device, "CURVES," developed at Johns Hopkins University and
reviewed in the February issue of Chest.
Fenofibrate Linked to Lower Creatinine Clearance
Long-term use of fenofibrate in type 2 diabetes is linked to lowered measures of renal function but
has no effect on albumin excretion rate, according to research published in the February issue of Diabetes
Care.
Vesicoureteral Reflux Treatment in Children Studied
The treating hospital is the most important factor affecting treatment choice in children with
vesicoureteral reflux, a condition characterized by an abnormal flow of urine from the bladder back into the
ureter, according to research published online Feb. 8 in Pediatrics.
Antiplatelet Therapy Approaches for PCI Evaluated
Patients who receive a loading dose of clopidogrel just before percutaneous coronary intervention have
similar ischemic and mortality outcomes to those who receive the antiplatelet therapy well in advance of the
procedure (as recommended in professional guidelines), according to research published in the Feb. 1 issue of the
American Journal of Cardiology.
Protein May Block Letrozole Therapy in Breast Cancer
The overexpression of low-molecular-weight cyclin E in the tumors of many menopausal women with
estrogen-receptor-positive breast cancers nullifies the effects of letrozole, an aromatase inhibitor. However,
letrozole's effect can be restored by adding the cyclin-dependent kinase 2 inhibitor roscovitine to treatment,
according to a study published online Feb. 9 in Clinical Cancer Research.
Systemic Treatment Deemed Effective for Giant-Cell Tumor
Denosumab, an antibody that targets cells involved in bone destruction, is the first systemic
treatment shown to be effective in treating giant-cell tumor, a rare osteolytic tumor that can metastasize to the
lung, according to a study published online Feb. 10 in The Lancet Oncology.
BP Drugs, Retinal Vessel Diameter in Diabetes Studied
In patients with type 1 diabetes mellitus who have normal blood pressure, neither
angiotensin-converting enzyme inhibitors nor angiotensin-receptor blockers have an effect on retinal arteriole or
venule diameter, according to a study in the February issue of the Archives of Ophthalmology.
Tamoxifen Treatment Linked to Worse Cognitive Function
Postmenopausal women with breast cancer have worse cognitive function after treatment with tamoxifen
but not exemestane, according to a study published online Feb. 8 in the Journal of Clinical Oncology.
Bedside Blood Test Found to Detect Anticoagulation Status
A new bedside blood test can be used to determine the sufficiency of anticoagulation in patients who
are about to undergo catheterization or percutaneous coronary intervention, according to a study in the Feb. 16
issue of the Journal of the American College of Cardiology.
Neutralizing Antibodies to Interferon Beta May Persist
After cessation of interferon beta therapy for relapsing-remitting multiple sclerosis, neutralizing
antibodies to interferon beta can persist, and their presence is associated with poorer clinical outcomes,
according to a study published online Feb. 8 in the Archives of Neurology.
Paroxetine May Compromise the Efficacy of Tamoxifen
Women with breast cancer who take tamoxifen and the antidepressant paroxetine (Paxil), which has been
hypothesized to reduce the effectiveness of tamoxifen, may be at higher risk of dying of breast cancer, according
to research published online Feb. 8 in BMJ.
Reimbursement Changes in Office Endoscopies Studied
A 2005 increase in Medicare reimbursement to encourage office-based endoscopic surgeries for bladder
cancer instead of more costly hospital surgeries had the unintended effect of disproportionately increasing
in-office procedures and driving up Medicare costs, according to a study published online Feb. 8 in
Cancer.
Outcomes Improving in Asymptomatic Carotid Stenosis
In patients with asymptomatic carotid stenosis, intensive medical therapy has significantly reduced
microemboli on transcranial Doppler as well as cardiovascular events, according to a study in the February issue of
the Archives of Neurology.
Behavioral Health Factors Linked to HPV Vaccination
Certain behavioral health factors may potentially be associated with human papillomavirus vaccine
acceptability, according to research published in the February issue of Cancer Epidemiology, Biomarkers
& Prevention.
Few Women Taking Tamoxifen to Prevent Breast Cancer
Well below 1 percent of American women without a personal history of breast cancer have been taking
tamoxifen to prevent breast cancer in the past decade, according to a report in the February issue of Cancer
Epidemiology, Biomarkers & Prevention.
Glaucoma Drugs Associated With Lower Mortality
Among glaucoma patients, the use of any class of glaucoma drug is associated with a significantly
lower likelihood of dying, according to a study published in the February issue of the Archives of
Ophthalmology.